InvestorsHub Logo
Followers 0
Posts 113
Boards Moderated 0
Alias Born 08/03/2007

Re: None

Wednesday, 09/24/2014 9:42:56 PM

Wednesday, September 24, 2014 9:42:56 PM

Post# of 2378
Data from Study of Champions Oncology TumorGrafts to be Presented at European Society for Medical Oncology (ESMO) 2014 Congress

HACKENSACK, N.J., Sept. 24, 2014 /PRNewswire/ -- Champions Oncology (CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that data from a study of Champions' TumorGrafts® will be presented on Monday, Sept. 29, at the European Society for Medical Oncology (ESMO) 2014 Congress.

Presentation Details

Title: Patient-derived xenografts accurately capture clinical responses to treatment
Session: Trials and tribulations in oncology: Future approaches
Abstract: 1573PD
Time: 1 p.m. CEST
Location: Pamplona (Hall 4)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CSBR News